Clinical and refractive outcomes of bilateral enhanced monofocal intraocular lens implantation with targeted mini-monovision - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clinical and Refractive Results After Bilateral Enhanced Monofocal IOL Implantation Using Targeted Mini-Monovision

  • By

  • Işıl Kefeli Kırcalı

  • Üzeyir Günenç

  • Canan Aslı Utine

  • Gül Arıkan

  • October 13, 2026

Share

  • 1

    This retrospective observational study evaluated 25 patients (50 eyes) who underwent bilateral RayOne EMV implantation between December 2022 and April 2024.

  • 2

    The protocol targeted emmetropia in the dominant eye and approximately −0.50 D in the nondominant eye.

  • 3

    All 25 patients met eligibility criteria, none were excluded or lost to follow-up, and Month 6 outcome data were complete.

  • 4

    The RayOne EMV is a non-diffractive enhanced monofocal IOL that uses controlled positive spherical aberration to extend depth of focus.

  • 5

    The study assessed visual, refractive, and patient-reported outcomes, including defocus profile and contrast sensitivity.

Original Source(s)

Clinical and refractive outcomes of bilateral enhanced monofocal intraocular lens implantation with targeted mini-monovision

  • by Işıl Kefeli Kırcalı, Üzeyir Günenç, Canan Aslı Utine, Gül Arıkan

  • October 13, 2026

Related Content

Rapidly progressive bilateral lens abnormalities following cataract surgery in a highly myopic patient

Image-Based Deep Learning for Cataract Diagnosis: Systematic Review and Meta-Analysis

Monofocal intraocular lens based on the Bessel principle for improved intermediate vision: a comparative assessment